Randy Stephen Coshatt, OD | |
112 5th St Ne, Aliceville, AL 35442-2200 | |
(205) 373-6374 | |
(205) 373-6163 |
Full Name | Randy Stephen Coshatt |
---|---|
Gender | Male |
Speciality | Optometrist |
Location | 112 5th St Ne, Aliceville, Alabama |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932103652 | NPI | - | NPPES |
0275270001 | Other | CIGNA GOVERNMENT SERVICES | |
51059452 | Other | AL | BLUE CROSS BLUE SHIELD |
000059452 | Medicaid | AL | |
0275270001 | Other | DMEPOS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | S-375-TA-023 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Randy Stephen Coshatt, OD 112 5th St Ne, Aliceville, AL 35442-2200 Ph: (205) 373-6374 | Randy Stephen Coshatt, OD 112 5th St Ne, Aliceville, AL 35442-2200 Ph: (205) 373-6374 |
News Archive
For the first time, scientists at the University of Wisconsin-Madison have made early retina structures containing proliferating neuroretinal progenitor cells using induced pluripotent stem (iPS) cells derived from human blood.
Dentists need to take a closer look at potential hazards of exposing patients to zinc, a common ingredient of many dental products, according to a report by Amar Patel, DDS, resident and colleagues at the University of Maryland Dental School in the March/April 2011 issue of the journal General Dentistry.
United Security Bancshares, Inc. today reported a net loss attributable to USBI of $348,000, or $0.06 per diluted share, for the second quarter ended June 30, 2010, compared with net income of $2.9 million, or $0.48 per diluted share, for the same period of 2009.
AIMM Therapeutics, a leading human therapeutic antibody company, today announced that its partner MedImmune, LLC, the global biologics unit of AstraZeneca, has initiated phase I clinical studies with MEDI8897, a best-in-class antibody for the treatment of respiratory syncytial virus (RSV) infections in young, at risk children.
› Verified 1 days ago